Author:
Shayo Grace A.,Chitama Dereck,Moshiro Candida,Aboud Said,Bakari Muhammad,Mugusi Ferdinand
Funder
U.S.A. National Institutes of Health (NIH) through the International Clinical, Operational and Health Services Research and Training Award (ICOHRTA)
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference28 articles.
1. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993 Jul;342(8866):268–72.
2. Mwinga A, Hosp M, Quigley M, Mwaba P, Mugala BN, Nyirenda O, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998;12:2447–57.
3. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons ( review ). Cochrane Libr. 2010;1:1–82.
4. Golub JE, Paul P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23(5):631–6.
5. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M, Sendi P, et al. Isoniazid prophylaxis for tuberculosis in HIV infection : a meta-analysis of randomized controlled trials. AIDS. 1999;13:501–7.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献